A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia

Pardee, T. S., Anderson, R. G., Pladna, K. M., Isom, S., Ghiraldeli, L. P., Miller, L. D., Chou, J. W., Jin, G., Zhang, W., Ellis, L. R., Berenzon, D., Howard, D. S., Hurd, D. D., Manuel, M., Dralle, S., Lyerly, S., Powell, B. L.
The American Association for Cancer Research (AACR)
Published 2018